To this end, we created a model wherein human donor PBMC with a demonstrated capacity to kill CAIX+ RCC cells by ADCC (Additional file 2: Figure S2) were injected into mice bearing an orthotopic RCC tumor. This evidence concerns the gene CA9 and neoplasm.